Largest ever Parkinson’s research trial is starting now
Date
Research news
Date
Back in the summer, we called upon the Parkinson’s community to take part in 5 clinical trials that were at a potential risk of closing. Thanks to you, we had an incredible response and want to keep up the momentum of encouraging people to take part in research.
Date
The biotech company NRG Therapeutics has received a large investment to continue its drug development project into life-changing new treatments.
Date
An international clinical trial looking at using stem cells to treat Parkinson’s has been granted approval to go ahead initially in Sweden.
Date
We’re investing £2m in Enterin’s phase 2 clinical trial of its drug ENT-01, a potential treatment for Parkinson’s dementia.
Date
Over the last 2 years, Vivifi Biotech has made progress towards a trial that aims to overcome the challenges of the last trial. Now, it’s starting work on the final phase of planning.
Date
A study following Scottish international rugby players shows they are more likely to develop neurodegenerative conditions compared to the general public.
Date
A project involving Parkinson’s UK, shows promise for using artificial intelligence to identify Parkinson’s in brains donated to our Brain Bank.
Date
Results from a US study show that a hormone called irisin has the potential to halt the progression of Parkinson’s in mice.
Date
Scientists at the University of Manchester have developed a test which could help diagnose Parkinson’s in 3 minutes using a simple skin swab.
Date
The £2.9m phase 2 trial of a drug that could slow the progression of conditions like Parkinson's will be funded by the Parkinson's Virtual Biotech, our international drug discovery and development programme.